报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 81.94% | -1.67% | -1.18% | 13/54 | 69.26% | 我武生物 | 95.26% | 行业排名> |
2024-06-30 | 82.92% | 0.82% | 5.35% | 12/54 | 68.54% | 西藏药业 | 95.7% | 行业排名> |
2024-03-31 | 78.72% | -3.74% | -5.79% | 17/54 | 69.17% | 康华生物 | 95.85% | 行业排名> |
2023-12-31 | 83.55% | -3.53% | 0.26% | 16/54 | 68.33% | 我武生物 | 95.26% | 行业排名> |
2023-09-30 | 83.33% | -4.66% | 1.32% | 16/54 | 68.07% | 我武生物 | 95.4% | 行业排名> |
2023-06-30 | 82.25% | -5.59% | 0.58% | 18/54 | 63.32% | 华兰疫苗 | 101.02% | 行业排名> |
2023-03-31 | 81.77% | -3.66% | -5.58% | 20/54 | 69.48% | 华兰疫苗 | 100.22% | 行业排名> |
2022-12-31 | 86.6% | -1.23% | -0.92% | 14/54 | 68.27% | 我武生物 | 95.39% | 行业排名> |
2022-09-30 | 87.41% | -0.32% | 0.34% | 15/54 | 71.28% | 我武生物 | 95.63% | 行业排名> |
2022-06-30 | 87.11% | -0.6% | 2.63% | 17/54 | 69.18% | 我武生物 | 95.75% | 行业排名> |
2022-03-31 | 84.88% | -1.68% | -3.19% | 19/54 | 71.63% | 华兰疫苗 | 98.39% | 行业排名> |
2021-12-31 | 87.68% | 0.71% | -0.01% | 17/54 | 72.33% | 百奥泰 | 95.74% | 行业排名> |
2021-09-30 | 87.69% | -0.76% | 0.06% | 16/54 | 73.87% | 我武生物 | 95.89% | 行业排名> |
2021-06-30 | 87.64% | 0.65% | 1.52% | 17/54 | 73.72% | 百奥泰 | 96.33% | 行业排名> |
2021-03-31 | 86.33% | 2% | -0.85% | 14/54 | 73.03% | 义翘神州 | 96.83% | 行业排名> |
2020-12-31 | 87.06% | -0.41% | -1.47% | 16/54 | 71.61% | 义翘神州 | 96.88% | 行业排名> |
2020-09-30 | 88.36% | 2% | 1.48% | 11/54 | 73.64% | 义翘神州 | 96.56% | 行业排名> |
2020-06-30 | 87.07% | 2% | -0.4% | 15/54 | 88.2% | 华兰疫苗 | 707.43% | 行业排名> |
2019-12-31 | 87.42% | 1.42% | 1.42% | 15/54 | 72.44% | 我武生物 | 95.6% | 行业排名> |
2018-12-31 | 86.2% | 2.36% | 2.36% | 12/54 | 71.54% | 我武生物 | 96.43% | 行业排名> |
2017-12-31 | 84.21% | 15.34% | 15.34% | 10/54 | -887.82% | 我武生物 | 96.51% | 行业排名> |
2015-12-31 | 73.01% | 6.84% | 6.84% | 12/54 | 65.23% | 我武生物 | 96.46% | 行业排名> |